Replies to post #12439 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

DFRAI,


You taking a lot of flak Jbog

Primarily because you never comment on much positives about the company.

Had it not been for the FDA mess with Lovenox and subsequent mess by the courts re MNTA patent/FDA disclosure of proprietary info - MNTA would have enjoyed additional revenue for a while.

Copaxone approval - 99.9% in my opinion, imminent launch.

This should carry the company until additional revenue is generated with Baxter and advancement of pipeline.

You're wrong, I do mention the positives about the company. Examples would be how the management makes off with oodles.

Then you go into the "had not's or if's". If New England didn't have so many fumbles or if they had stopped Miami from scoring they would have won over the weekend.

If there were a fraction of the positives you claim the stock wouldn't be at eleven bucks, unless of course if the market is irrational.